WallStreetZenWallStreetZen

NASDAQ: ADIL
Adial Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ADIL stock forecasts and price targets.

Forecast return on equity

Is ADIL forecast to generate an efficient return?

Company
N/A
Industry
164.98%
Market
89.42%

Forecast return on assets

Is ADIL forecast to generate an efficient return on assets?

Company
N/A
Industry
43.44%

ADIL earnings per share forecast

What is ADIL's earnings per share in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.89

ADIL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ADIL$0.33N/AN/A
ADTX$1.23N/AN/A
JAGX$2.58$60.00+2,225.58%Strong Buy
ONCO$4.65N/AN/A
SILO$0.62N/AN/A
View Top Biotech Stocks

Adial Pharmaceuticals Stock Forecast FAQ

What is ADIL's earnings growth forecast for 2025-2025?

(NASDAQ: ADIL) Adial Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.76%.

Adial Pharmaceuticals's earnings in 2025 is -$8,949,692.

In 2025, ADIL is forecast to generate -$6,992,115 in earnings, with the lowest earnings forecast at -$9,638,848 and the highest earnings forecast at -$4,345,382.

If you're new to stock investing, here's how to buy Adial Pharmaceuticals stock.

What is ADIL's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ADIL) forecast ROE is N/A, which is considered weak.

What is ADIL's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ADIL) Adial Pharmaceuticals's current Earnings Per Share (EPS) is -$1.46. In 2025, ADIL's EPS is forecast to hit -$0.89 (min: -$1.22, max: -$0.55).

What is ADIL's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ADIL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 43.44%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.